Global Covid-19 Protein Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The human coronavirus nucleoprotein (N protein) is a crucial component of the coronavirus virion (virus particle). Coronaviruses are a family of viruses that can cause respiratory illnesses in humans and animals.
The global Covid-19 Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Covid-19 Protein Industry Forecast” looks at past sales and reviews total world Covid-19 Protein sales in 2023, providing a comprehensive analysis by region and market sector of projected Covid-19 Protein sales for 2024 through 2030. With Covid-19 Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covid-19 Protein industry.
This Insight Report provides a comprehensive analysis of the global Covid-19 Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covid-19 Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covid-19 Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covid-19 Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covid-19 Protein.
United States market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Covid-19 Protein players cover Abcam, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Covid-19 Protein market?
What factors are driving Covid-19 Protein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Covid-19 Protein market opportunities vary by end market size?
How does Covid-19 Protein break out by Type, by Application?
The human coronavirus nucleoprotein (N protein) is a crucial component of the coronavirus virion (virus particle). Coronaviruses are a family of viruses that can cause respiratory illnesses in humans and animals.
The global Covid-19 Protein market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Covid-19 Protein Industry Forecast” looks at past sales and reviews total world Covid-19 Protein sales in 2023, providing a comprehensive analysis by region and market sector of projected Covid-19 Protein sales for 2024 through 2030. With Covid-19 Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covid-19 Protein industry.
This Insight Report provides a comprehensive analysis of the global Covid-19 Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covid-19 Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covid-19 Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covid-19 Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covid-19 Protein.
United States market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Covid-19 Protein is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Covid-19 Protein players cover Abcam, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 90%?Purity?95%
- Purity?95%
- Other
- Vaccine Development
- Antiviral Drugs
- Research
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abcam
- The Native Antigen Company
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Agrisera
- Merck KGaA (Sigma-Aldrich)
- Seebio
- Elabscience
- Novus Biologicals
- Sinobiological
- Eagle Biosciences
- BiosPacific
What is the 10-year outlook for the global Covid-19 Protein market?
What factors are driving Covid-19 Protein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Covid-19 Protein market opportunities vary by end market size?
How does Covid-19 Protein break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covid-19 Protein Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Covid-19 Protein by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Covid-19 Protein by Country/Region, 2019, 2023 & 2030
2.2 Covid-19 Protein Segment by Type
2.2.1 90%?Purity?95%
2.2.2 Purity?95%
2.2.3 Other
2.3 Covid-19 Protein Sales by Type
2.3.1 Global Covid-19 Protein Sales Market Share by Type (2019-2024)
2.3.2 Global Covid-19 Protein Revenue and Market Share by Type (2019-2024)
2.3.3 Global Covid-19 Protein Sale Price by Type (2019-2024)
2.4 Covid-19 Protein Segment by Application
2.4.1 Vaccine Development
2.4.2 Antiviral Drugs
2.4.3 Research
2.4.4 Other
2.5 Covid-19 Protein Sales by Application
2.5.1 Global Covid-19 Protein Sale Market Share by Application (2019-2024)
2.5.2 Global Covid-19 Protein Revenue and Market Share by Application (2019-2024)
2.5.3 Global Covid-19 Protein Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Covid-19 Protein Breakdown Data by Company
3.1.1 Global Covid-19 Protein Annual Sales by Company (2019-2024)
3.1.2 Global Covid-19 Protein Sales Market Share by Company (2019-2024)
3.2 Global Covid-19 Protein Annual Revenue by Company (2019-2024)
3.2.1 Global Covid-19 Protein Revenue by Company (2019-2024)
3.2.2 Global Covid-19 Protein Revenue Market Share by Company (2019-2024)
3.3 Global Covid-19 Protein Sale Price by Company
3.4 Key Manufacturers Covid-19 Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Covid-19 Protein Product Location Distribution
3.4.2 Players Covid-19 Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COVID-19 PROTEIN BY GEOGRAPHIC REGION
4.1 World Historic Covid-19 Protein Market Size by Geographic Region (2019-2024)
4.1.1 Global Covid-19 Protein Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Covid-19 Protein Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Covid-19 Protein Market Size by Country/Region (2019-2024)
4.2.1 Global Covid-19 Protein Annual Sales by Country/Region (2019-2024)
4.2.2 Global Covid-19 Protein Annual Revenue by Country/Region (2019-2024)
4.3 Americas Covid-19 Protein Sales Growth
4.4 APAC Covid-19 Protein Sales Growth
4.5 Europe Covid-19 Protein Sales Growth
4.6 Middle East & Africa Covid-19 Protein Sales Growth
5 AMERICAS
5.1 Americas Covid-19 Protein Sales by Country
5.1.1 Americas Covid-19 Protein Sales by Country (2019-2024)
5.1.2 Americas Covid-19 Protein Revenue by Country (2019-2024)
5.2 Americas Covid-19 Protein Sales by Type (2019-2024)
5.3 Americas Covid-19 Protein Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Protein Sales by Region
6.1.1 APAC Covid-19 Protein Sales by Region (2019-2024)
6.1.2 APAC Covid-19 Protein Revenue by Region (2019-2024)
6.2 APAC Covid-19 Protein Sales by Type (2019-2024)
6.3 APAC Covid-19 Protein Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Covid-19 Protein by Country
7.1.1 Europe Covid-19 Protein Sales by Country (2019-2024)
7.1.2 Europe Covid-19 Protein Revenue by Country (2019-2024)
7.2 Europe Covid-19 Protein Sales by Type (2019-2024)
7.3 Europe Covid-19 Protein Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covid-19 Protein by Country
8.1.1 Middle East & Africa Covid-19 Protein Sales by Country (2019-2024)
8.1.2 Middle East & Africa Covid-19 Protein Revenue by Country (2019-2024)
8.2 Middle East & Africa Covid-19 Protein Sales by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Protein Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Covid-19 Protein
10.3 Manufacturing Process Analysis of Covid-19 Protein
10.4 Industry Chain Structure of Covid-19 Protein
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Covid-19 Protein Distributors
11.3 Covid-19 Protein Customer
12 WORLD FORECAST REVIEW FOR COVID-19 PROTEIN BY GEOGRAPHIC REGION
12.1 Global Covid-19 Protein Market Size Forecast by Region
12.1.1 Global Covid-19 Protein Forecast by Region (2025-2030)
12.1.2 Global Covid-19 Protein Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Covid-19 Protein Forecast by Type (2025-2030)
12.7 Global Covid-19 Protein Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Abcam
13.1.1 Abcam Company Information
13.1.2 Abcam Covid-19 Protein Product Portfolios and Specifications
13.1.3 Abcam Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abcam Main Business Overview
13.1.5 Abcam Latest Developments
13.2 The Native Antigen Company
13.2.1 The Native Antigen Company Company Information
13.2.2 The Native Antigen Company Covid-19 Protein Product Portfolios and Specifications
13.2.3 The Native Antigen Company Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 The Native Antigen Company Main Business Overview
13.2.5 The Native Antigen Company Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Covid-19 Protein Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Covid-19 Protein Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Agrisera
13.5.1 Agrisera Company Information
13.5.2 Agrisera Covid-19 Protein Product Portfolios and Specifications
13.5.3 Agrisera Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Agrisera Main Business Overview
13.5.5 Agrisera Latest Developments
13.6 Merck KGaA (Sigma-Aldrich)
13.6.1 Merck KGaA (Sigma-Aldrich) Company Information
13.6.2 Merck KGaA (Sigma-Aldrich) Covid-19 Protein Product Portfolios and Specifications
13.6.3 Merck KGaA (Sigma-Aldrich) Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck KGaA (Sigma-Aldrich) Main Business Overview
13.6.5 Merck KGaA (Sigma-Aldrich) Latest Developments
13.7 Seebio
13.7.1 Seebio Company Information
13.7.2 Seebio Covid-19 Protein Product Portfolios and Specifications
13.7.3 Seebio Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Seebio Main Business Overview
13.7.5 Seebio Latest Developments
13.8 Elabscience
13.8.1 Elabscience Company Information
13.8.2 Elabscience Covid-19 Protein Product Portfolios and Specifications
13.8.3 Elabscience Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Elabscience Main Business Overview
13.8.5 Elabscience Latest Developments
13.9 Novus Biologicals
13.9.1 Novus Biologicals Company Information
13.9.2 Novus Biologicals Covid-19 Protein Product Portfolios and Specifications
13.9.3 Novus Biologicals Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Novus Biologicals Main Business Overview
13.9.5 Novus Biologicals Latest Developments
13.10 Sinobiological
13.10.1 Sinobiological Company Information
13.10.2 Sinobiological Covid-19 Protein Product Portfolios and Specifications
13.10.3 Sinobiological Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sinobiological Main Business Overview
13.10.5 Sinobiological Latest Developments
13.11 Eagle Biosciences
13.11.1 Eagle Biosciences Company Information
13.11.2 Eagle Biosciences Covid-19 Protein Product Portfolios and Specifications
13.11.3 Eagle Biosciences Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Eagle Biosciences Main Business Overview
13.11.5 Eagle Biosciences Latest Developments
13.12 BiosPacific
13.12.1 BiosPacific Company Information
13.12.2 BiosPacific Covid-19 Protein Product Portfolios and Specifications
13.12.3 BiosPacific Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BiosPacific Main Business Overview
13.12.5 BiosPacific Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covid-19 Protein Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Covid-19 Protein by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Covid-19 Protein by Country/Region, 2019, 2023 & 2030
2.2 Covid-19 Protein Segment by Type
2.2.1 90%?Purity?95%
2.2.2 Purity?95%
2.2.3 Other
2.3 Covid-19 Protein Sales by Type
2.3.1 Global Covid-19 Protein Sales Market Share by Type (2019-2024)
2.3.2 Global Covid-19 Protein Revenue and Market Share by Type (2019-2024)
2.3.3 Global Covid-19 Protein Sale Price by Type (2019-2024)
2.4 Covid-19 Protein Segment by Application
2.4.1 Vaccine Development
2.4.2 Antiviral Drugs
2.4.3 Research
2.4.4 Other
2.5 Covid-19 Protein Sales by Application
2.5.1 Global Covid-19 Protein Sale Market Share by Application (2019-2024)
2.5.2 Global Covid-19 Protein Revenue and Market Share by Application (2019-2024)
2.5.3 Global Covid-19 Protein Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Covid-19 Protein Breakdown Data by Company
3.1.1 Global Covid-19 Protein Annual Sales by Company (2019-2024)
3.1.2 Global Covid-19 Protein Sales Market Share by Company (2019-2024)
3.2 Global Covid-19 Protein Annual Revenue by Company (2019-2024)
3.2.1 Global Covid-19 Protein Revenue by Company (2019-2024)
3.2.2 Global Covid-19 Protein Revenue Market Share by Company (2019-2024)
3.3 Global Covid-19 Protein Sale Price by Company
3.4 Key Manufacturers Covid-19 Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Covid-19 Protein Product Location Distribution
3.4.2 Players Covid-19 Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COVID-19 PROTEIN BY GEOGRAPHIC REGION
4.1 World Historic Covid-19 Protein Market Size by Geographic Region (2019-2024)
4.1.1 Global Covid-19 Protein Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Covid-19 Protein Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Covid-19 Protein Market Size by Country/Region (2019-2024)
4.2.1 Global Covid-19 Protein Annual Sales by Country/Region (2019-2024)
4.2.2 Global Covid-19 Protein Annual Revenue by Country/Region (2019-2024)
4.3 Americas Covid-19 Protein Sales Growth
4.4 APAC Covid-19 Protein Sales Growth
4.5 Europe Covid-19 Protein Sales Growth
4.6 Middle East & Africa Covid-19 Protein Sales Growth
5 AMERICAS
5.1 Americas Covid-19 Protein Sales by Country
5.1.1 Americas Covid-19 Protein Sales by Country (2019-2024)
5.1.2 Americas Covid-19 Protein Revenue by Country (2019-2024)
5.2 Americas Covid-19 Protein Sales by Type (2019-2024)
5.3 Americas Covid-19 Protein Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Protein Sales by Region
6.1.1 APAC Covid-19 Protein Sales by Region (2019-2024)
6.1.2 APAC Covid-19 Protein Revenue by Region (2019-2024)
6.2 APAC Covid-19 Protein Sales by Type (2019-2024)
6.3 APAC Covid-19 Protein Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Covid-19 Protein by Country
7.1.1 Europe Covid-19 Protein Sales by Country (2019-2024)
7.1.2 Europe Covid-19 Protein Revenue by Country (2019-2024)
7.2 Europe Covid-19 Protein Sales by Type (2019-2024)
7.3 Europe Covid-19 Protein Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covid-19 Protein by Country
8.1.1 Middle East & Africa Covid-19 Protein Sales by Country (2019-2024)
8.1.2 Middle East & Africa Covid-19 Protein Revenue by Country (2019-2024)
8.2 Middle East & Africa Covid-19 Protein Sales by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Protein Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Covid-19 Protein
10.3 Manufacturing Process Analysis of Covid-19 Protein
10.4 Industry Chain Structure of Covid-19 Protein
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Covid-19 Protein Distributors
11.3 Covid-19 Protein Customer
12 WORLD FORECAST REVIEW FOR COVID-19 PROTEIN BY GEOGRAPHIC REGION
12.1 Global Covid-19 Protein Market Size Forecast by Region
12.1.1 Global Covid-19 Protein Forecast by Region (2025-2030)
12.1.2 Global Covid-19 Protein Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Covid-19 Protein Forecast by Type (2025-2030)
12.7 Global Covid-19 Protein Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Abcam
13.1.1 Abcam Company Information
13.1.2 Abcam Covid-19 Protein Product Portfolios and Specifications
13.1.3 Abcam Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abcam Main Business Overview
13.1.5 Abcam Latest Developments
13.2 The Native Antigen Company
13.2.1 The Native Antigen Company Company Information
13.2.2 The Native Antigen Company Covid-19 Protein Product Portfolios and Specifications
13.2.3 The Native Antigen Company Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 The Native Antigen Company Main Business Overview
13.2.5 The Native Antigen Company Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Covid-19 Protein Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Covid-19 Protein Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Agrisera
13.5.1 Agrisera Company Information
13.5.2 Agrisera Covid-19 Protein Product Portfolios and Specifications
13.5.3 Agrisera Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Agrisera Main Business Overview
13.5.5 Agrisera Latest Developments
13.6 Merck KGaA (Sigma-Aldrich)
13.6.1 Merck KGaA (Sigma-Aldrich) Company Information
13.6.2 Merck KGaA (Sigma-Aldrich) Covid-19 Protein Product Portfolios and Specifications
13.6.3 Merck KGaA (Sigma-Aldrich) Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck KGaA (Sigma-Aldrich) Main Business Overview
13.6.5 Merck KGaA (Sigma-Aldrich) Latest Developments
13.7 Seebio
13.7.1 Seebio Company Information
13.7.2 Seebio Covid-19 Protein Product Portfolios and Specifications
13.7.3 Seebio Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Seebio Main Business Overview
13.7.5 Seebio Latest Developments
13.8 Elabscience
13.8.1 Elabscience Company Information
13.8.2 Elabscience Covid-19 Protein Product Portfolios and Specifications
13.8.3 Elabscience Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Elabscience Main Business Overview
13.8.5 Elabscience Latest Developments
13.9 Novus Biologicals
13.9.1 Novus Biologicals Company Information
13.9.2 Novus Biologicals Covid-19 Protein Product Portfolios and Specifications
13.9.3 Novus Biologicals Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Novus Biologicals Main Business Overview
13.9.5 Novus Biologicals Latest Developments
13.10 Sinobiological
13.10.1 Sinobiological Company Information
13.10.2 Sinobiological Covid-19 Protein Product Portfolios and Specifications
13.10.3 Sinobiological Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Sinobiological Main Business Overview
13.10.5 Sinobiological Latest Developments
13.11 Eagle Biosciences
13.11.1 Eagle Biosciences Company Information
13.11.2 Eagle Biosciences Covid-19 Protein Product Portfolios and Specifications
13.11.3 Eagle Biosciences Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Eagle Biosciences Main Business Overview
13.11.5 Eagle Biosciences Latest Developments
13.12 BiosPacific
13.12.1 BiosPacific Company Information
13.12.2 BiosPacific Covid-19 Protein Product Portfolios and Specifications
13.12.3 BiosPacific Covid-19 Protein Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BiosPacific Main Business Overview
13.12.5 BiosPacific Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Covid-19 Protein Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Covid-19 Protein Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 90%?Purity?95%
Table 4. Major Players of Purity?95%
Table 5. Major Players of Other
Table 6. Global Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 7. Global Covid-19 Protein Sales Market Share by Type (2019-2024)
Table 8. Global Covid-19 Protein Revenue by Type (2019-2024) & ($ million)
Table 9. Global Covid-19 Protein Revenue Market Share by Type (2019-2024)
Table 10. Global Covid-19 Protein Sale Price by Type (2019-2024) & (US$/kg)
Table 11. Global Covid-19 Protein Sale by Application (2019-2024) & (kg)
Table 12. Global Covid-19 Protein Sale Market Share by Application (2019-2024)
Table 13. Global Covid-19 Protein Revenue by Application (2019-2024) & ($ million)
Table 14. Global Covid-19 Protein Revenue Market Share by Application (2019-2024)
Table 15. Global Covid-19 Protein Sale Price by Application (2019-2024) & (US$/kg)
Table 16. Global Covid-19 Protein Sales by Company (2019-2024) & (kg)
Table 17. Global Covid-19 Protein Sales Market Share by Company (2019-2024)
Table 18. Global Covid-19 Protein Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Covid-19 Protein Revenue Market Share by Company (2019-2024)
Table 20. Global Covid-19 Protein Sale Price by Company (2019-2024) & (US$/kg)
Table 21. Key Manufacturers Covid-19 Protein Producing Area Distribution and Sales Area
Table 22. Players Covid-19 Protein Products Offered
Table 23. Covid-19 Protein Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Covid-19 Protein Sales by Geographic Region (2019-2024) & (kg)
Table 27. Global Covid-19 Protein Sales Market Share Geographic Region (2019-2024)
Table 28. Global Covid-19 Protein Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Covid-19 Protein Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Covid-19 Protein Sales by Country/Region (2019-2024) & (kg)
Table 31. Global Covid-19 Protein Sales Market Share by Country/Region (2019-2024)
Table 32. Global Covid-19 Protein Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Covid-19 Protein Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 35. Americas Covid-19 Protein Sales Market Share by Country (2019-2024)
Table 36. Americas Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 38. Americas Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 39. APAC Covid-19 Protein Sales by Region (2019-2024) & (kg)
Table 40. APAC Covid-19 Protein Sales Market Share by Region (2019-2024)
Table 41. APAC Covid-19 Protein Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 43. APAC Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 44. Europe Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 45. Europe Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 47. Europe Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 48. Middle East & Africa Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 49. Middle East & Africa Covid-19 Protein Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 51. Middle East & Africa Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Covid-19 Protein
Table 53. Key Market Challenges & Risks of Covid-19 Protein
Table 54. Key Industry Trends of Covid-19 Protein
Table 55. Covid-19 Protein Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Covid-19 Protein Distributors List
Table 58. Covid-19 Protein Customer List
Table 59. Global Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 60. Global Covid-19 Protein Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 62. Americas Covid-19 Protein Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 64. APAC Covid-19 Protein Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 66. Europe Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 68. Middle East & Africa Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Covid-19 Protein Sales Forecast by Type (2025-2030) & (kg)
Table 70. Global Covid-19 Protein Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Covid-19 Protein Sales Forecast by Application (2025-2030) & (kg)
Table 72. Global Covid-19 Protein Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Abcam Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 74. Abcam Covid-19 Protein Product Portfolios and Specifications
Table 75. Abcam Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 76. Abcam Main Business
Table 77. Abcam Latest Developments
Table 78. The Native Antigen Company Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 79. The Native Antigen Company Covid-19 Protein Product Portfolios and Specifications
Table 80. The Native Antigen Company Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 81. The Native Antigen Company Main Business
Table 82. The Native Antigen Company Latest Developments
Table 83. Bio-Rad Laboratories Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Rad Laboratories Covid-19 Protein Product Portfolios and Specifications
Table 85. Bio-Rad Laboratories Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 86. Bio-Rad Laboratories Main Business
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. Thermo Fisher Scientific Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Covid-19 Protein Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Agrisera Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 94. Agrisera Covid-19 Protein Product Portfolios and Specifications
Table 95. Agrisera Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 96. Agrisera Main Business
Table 97. Agrisera Latest Developments
Table 98. Merck KGaA (Sigma-Aldrich) Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck KGaA (Sigma-Aldrich) Covid-19 Protein Product Portfolios and Specifications
Table 100. Merck KGaA (Sigma-Aldrich) Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 101. Merck KGaA (Sigma-Aldrich) Main Business
Table 102. Merck KGaA (Sigma-Aldrich) Latest Developments
Table 103. Seebio Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 104. Seebio Covid-19 Protein Product Portfolios and Specifications
Table 105. Seebio Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 106. Seebio Main Business
Table 107. Seebio Latest Developments
Table 108. Elabscience Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 109. Elabscience Covid-19 Protein Product Portfolios and Specifications
Table 110. Elabscience Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 111. Elabscience Main Business
Table 112. Elabscience Latest Developments
Table 113. Novus Biologicals Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 114. Novus Biologicals Covid-19 Protein Product Portfolios and Specifications
Table 115. Novus Biologicals Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 116. Novus Biologicals Main Business
Table 117. Novus Biologicals Latest Developments
Table 118. Sinobiological Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinobiological Covid-19 Protein Product Portfolios and Specifications
Table 120. Sinobiological Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 121. Sinobiological Main Business
Table 122. Sinobiological Latest Developments
Table 123. Eagle Biosciences Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 124. Eagle Biosciences Covid-19 Protein Product Portfolios and Specifications
Table 125. Eagle Biosciences Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 126. Eagle Biosciences Main Business
Table 127. Eagle Biosciences Latest Developments
Table 128. BiosPacific Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 129. BiosPacific Covid-19 Protein Product Portfolios and Specifications
Table 130. BiosPacific Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 131. BiosPacific Main Business
Table 132. BiosPacific Latest Developments
Table 1. Covid-19 Protein Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Covid-19 Protein Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 90%?Purity?95%
Table 4. Major Players of Purity?95%
Table 5. Major Players of Other
Table 6. Global Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 7. Global Covid-19 Protein Sales Market Share by Type (2019-2024)
Table 8. Global Covid-19 Protein Revenue by Type (2019-2024) & ($ million)
Table 9. Global Covid-19 Protein Revenue Market Share by Type (2019-2024)
Table 10. Global Covid-19 Protein Sale Price by Type (2019-2024) & (US$/kg)
Table 11. Global Covid-19 Protein Sale by Application (2019-2024) & (kg)
Table 12. Global Covid-19 Protein Sale Market Share by Application (2019-2024)
Table 13. Global Covid-19 Protein Revenue by Application (2019-2024) & ($ million)
Table 14. Global Covid-19 Protein Revenue Market Share by Application (2019-2024)
Table 15. Global Covid-19 Protein Sale Price by Application (2019-2024) & (US$/kg)
Table 16. Global Covid-19 Protein Sales by Company (2019-2024) & (kg)
Table 17. Global Covid-19 Protein Sales Market Share by Company (2019-2024)
Table 18. Global Covid-19 Protein Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Covid-19 Protein Revenue Market Share by Company (2019-2024)
Table 20. Global Covid-19 Protein Sale Price by Company (2019-2024) & (US$/kg)
Table 21. Key Manufacturers Covid-19 Protein Producing Area Distribution and Sales Area
Table 22. Players Covid-19 Protein Products Offered
Table 23. Covid-19 Protein Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Covid-19 Protein Sales by Geographic Region (2019-2024) & (kg)
Table 27. Global Covid-19 Protein Sales Market Share Geographic Region (2019-2024)
Table 28. Global Covid-19 Protein Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Covid-19 Protein Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Covid-19 Protein Sales by Country/Region (2019-2024) & (kg)
Table 31. Global Covid-19 Protein Sales Market Share by Country/Region (2019-2024)
Table 32. Global Covid-19 Protein Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Covid-19 Protein Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 35. Americas Covid-19 Protein Sales Market Share by Country (2019-2024)
Table 36. Americas Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 38. Americas Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 39. APAC Covid-19 Protein Sales by Region (2019-2024) & (kg)
Table 40. APAC Covid-19 Protein Sales Market Share by Region (2019-2024)
Table 41. APAC Covid-19 Protein Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 43. APAC Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 44. Europe Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 45. Europe Covid-19 Protein Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 47. Europe Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 48. Middle East & Africa Covid-19 Protein Sales by Country (2019-2024) & (kg)
Table 49. Middle East & Africa Covid-19 Protein Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Covid-19 Protein Sales by Type (2019-2024) & (kg)
Table 51. Middle East & Africa Covid-19 Protein Sales by Application (2019-2024) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Covid-19 Protein
Table 53. Key Market Challenges & Risks of Covid-19 Protein
Table 54. Key Industry Trends of Covid-19 Protein
Table 55. Covid-19 Protein Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Covid-19 Protein Distributors List
Table 58. Covid-19 Protein Customer List
Table 59. Global Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 60. Global Covid-19 Protein Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 62. Americas Covid-19 Protein Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Covid-19 Protein Sales Forecast by Region (2025-2030) & (kg)
Table 64. APAC Covid-19 Protein Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 66. Europe Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Covid-19 Protein Sales Forecast by Country (2025-2030) & (kg)
Table 68. Middle East & Africa Covid-19 Protein Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Covid-19 Protein Sales Forecast by Type (2025-2030) & (kg)
Table 70. Global Covid-19 Protein Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Covid-19 Protein Sales Forecast by Application (2025-2030) & (kg)
Table 72. Global Covid-19 Protein Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Abcam Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 74. Abcam Covid-19 Protein Product Portfolios and Specifications
Table 75. Abcam Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 76. Abcam Main Business
Table 77. Abcam Latest Developments
Table 78. The Native Antigen Company Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 79. The Native Antigen Company Covid-19 Protein Product Portfolios and Specifications
Table 80. The Native Antigen Company Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 81. The Native Antigen Company Main Business
Table 82. The Native Antigen Company Latest Developments
Table 83. Bio-Rad Laboratories Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Rad Laboratories Covid-19 Protein Product Portfolios and Specifications
Table 85. Bio-Rad Laboratories Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 86. Bio-Rad Laboratories Main Business
Table 87. Bio-Rad Laboratories Latest Developments
Table 88. Thermo Fisher Scientific Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher Scientific Covid-19 Protein Product Portfolios and Specifications
Table 90. Thermo Fisher Scientific Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 91. Thermo Fisher Scientific Main Business
Table 92. Thermo Fisher Scientific Latest Developments
Table 93. Agrisera Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 94. Agrisera Covid-19 Protein Product Portfolios and Specifications
Table 95. Agrisera Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 96. Agrisera Main Business
Table 97. Agrisera Latest Developments
Table 98. Merck KGaA (Sigma-Aldrich) Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck KGaA (Sigma-Aldrich) Covid-19 Protein Product Portfolios and Specifications
Table 100. Merck KGaA (Sigma-Aldrich) Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 101. Merck KGaA (Sigma-Aldrich) Main Business
Table 102. Merck KGaA (Sigma-Aldrich) Latest Developments
Table 103. Seebio Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 104. Seebio Covid-19 Protein Product Portfolios and Specifications
Table 105. Seebio Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 106. Seebio Main Business
Table 107. Seebio Latest Developments
Table 108. Elabscience Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 109. Elabscience Covid-19 Protein Product Portfolios and Specifications
Table 110. Elabscience Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 111. Elabscience Main Business
Table 112. Elabscience Latest Developments
Table 113. Novus Biologicals Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 114. Novus Biologicals Covid-19 Protein Product Portfolios and Specifications
Table 115. Novus Biologicals Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 116. Novus Biologicals Main Business
Table 117. Novus Biologicals Latest Developments
Table 118. Sinobiological Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinobiological Covid-19 Protein Product Portfolios and Specifications
Table 120. Sinobiological Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 121. Sinobiological Main Business
Table 122. Sinobiological Latest Developments
Table 123. Eagle Biosciences Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 124. Eagle Biosciences Covid-19 Protein Product Portfolios and Specifications
Table 125. Eagle Biosciences Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 126. Eagle Biosciences Main Business
Table 127. Eagle Biosciences Latest Developments
Table 128. BiosPacific Basic Information, Covid-19 Protein Manufacturing Base, Sales Area and Its Competitors
Table 129. BiosPacific Covid-19 Protein Product Portfolios and Specifications
Table 130. BiosPacific Covid-19 Protein Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 131. BiosPacific Main Business
Table 132. BiosPacific Latest Developments
LIST OF FIGURES
Figure 1. Picture of Covid-19 Protein
Figure 2. Covid-19 Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Covid-19 Protein Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Covid-19 Protein Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Covid-19 Protein Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Covid-19 Protein Sales Market Share by Country/Region (2023)
Figure 10. Covid-19 Protein Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 90%?Purity?95%
Figure 12. Product Picture of Purity?95%
Figure 13. Product Picture of Other
Figure 14. Global Covid-19 Protein Sales Market Share by Type in 2023
Figure 15. Global Covid-19 Protein Revenue Market Share by Type (2019-2024)
Figure 16. Covid-19 Protein Consumed in Vaccine Development
Figure 17. Global Covid-19 Protein Market: Vaccine Development (2019-2024) & (kg)
Figure 18. Covid-19 Protein Consumed in Antiviral Drugs
Figure 19. Global Covid-19 Protein Market: Antiviral Drugs (2019-2024) & (kg)
Figure 20. Covid-19 Protein Consumed in Research
Figure 21. Global Covid-19 Protein Market: Research (2019-2024) & (kg)
Figure 22. Covid-19 Protein Consumed in Other
Figure 23. Global Covid-19 Protein Market: Other (2019-2024) & (kg)
Figure 24. Global Covid-19 Protein Sale Market Share by Application (2023)
Figure 25. Global Covid-19 Protein Revenue Market Share by Application in 2023
Figure 26. Covid-19 Protein Sales by Company in 2023 (kg)
Figure 27. Global Covid-19 Protein Sales Market Share by Company in 2023
Figure 28. Covid-19 Protein Revenue by Company in 2023 ($ millions)
Figure 29. Global Covid-19 Protein Revenue Market Share by Company in 2023
Figure 30. Global Covid-19 Protein Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Covid-19 Protein Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Covid-19 Protein Sales 2019-2024 (kg)
Figure 33. Americas Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 34. APAC Covid-19 Protein Sales 2019-2024 (kg)
Figure 35. APAC Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 36. Europe Covid-19 Protein Sales 2019-2024 (kg)
Figure 37. Europe Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Covid-19 Protein Sales 2019-2024 (kg)
Figure 39. Middle East & Africa Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 40. Americas Covid-19 Protein Sales Market Share by Country in 2023
Figure 41. Americas Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 42. Americas Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 43. Americas Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 44. United States Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Covid-19 Protein Sales Market Share by Region in 2023
Figure 49. APAC Covid-19 Protein Revenue Market Share by Region (2019-2024)
Figure 50. APAC Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 51. APAC Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 52. China Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 56. India Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Covid-19 Protein Sales Market Share by Country in 2023
Figure 60. Europe Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 61. Europe Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 62. Europe Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 63. Germany Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 64. France Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Covid-19 Protein Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 71. Egypt Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Covid-19 Protein in 2023
Figure 77. Manufacturing Process Analysis of Covid-19 Protein
Figure 78. Industry Chain Structure of Covid-19 Protein
Figure 79. Channels of Distribution
Figure 80. Global Covid-19 Protein Sales Market Forecast by Region (2025-2030)
Figure 81. Global Covid-19 Protein Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Covid-19 Protein Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Covid-19 Protein Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Covid-19 Protein Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Covid-19 Protein Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Covid-19 Protein
Figure 2. Covid-19 Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Covid-19 Protein Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Covid-19 Protein Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Covid-19 Protein Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Covid-19 Protein Sales Market Share by Country/Region (2023)
Figure 10. Covid-19 Protein Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 90%?Purity?95%
Figure 12. Product Picture of Purity?95%
Figure 13. Product Picture of Other
Figure 14. Global Covid-19 Protein Sales Market Share by Type in 2023
Figure 15. Global Covid-19 Protein Revenue Market Share by Type (2019-2024)
Figure 16. Covid-19 Protein Consumed in Vaccine Development
Figure 17. Global Covid-19 Protein Market: Vaccine Development (2019-2024) & (kg)
Figure 18. Covid-19 Protein Consumed in Antiviral Drugs
Figure 19. Global Covid-19 Protein Market: Antiviral Drugs (2019-2024) & (kg)
Figure 20. Covid-19 Protein Consumed in Research
Figure 21. Global Covid-19 Protein Market: Research (2019-2024) & (kg)
Figure 22. Covid-19 Protein Consumed in Other
Figure 23. Global Covid-19 Protein Market: Other (2019-2024) & (kg)
Figure 24. Global Covid-19 Protein Sale Market Share by Application (2023)
Figure 25. Global Covid-19 Protein Revenue Market Share by Application in 2023
Figure 26. Covid-19 Protein Sales by Company in 2023 (kg)
Figure 27. Global Covid-19 Protein Sales Market Share by Company in 2023
Figure 28. Covid-19 Protein Revenue by Company in 2023 ($ millions)
Figure 29. Global Covid-19 Protein Revenue Market Share by Company in 2023
Figure 30. Global Covid-19 Protein Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Covid-19 Protein Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Covid-19 Protein Sales 2019-2024 (kg)
Figure 33. Americas Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 34. APAC Covid-19 Protein Sales 2019-2024 (kg)
Figure 35. APAC Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 36. Europe Covid-19 Protein Sales 2019-2024 (kg)
Figure 37. Europe Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Covid-19 Protein Sales 2019-2024 (kg)
Figure 39. Middle East & Africa Covid-19 Protein Revenue 2019-2024 ($ millions)
Figure 40. Americas Covid-19 Protein Sales Market Share by Country in 2023
Figure 41. Americas Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 42. Americas Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 43. Americas Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 44. United States Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Covid-19 Protein Sales Market Share by Region in 2023
Figure 49. APAC Covid-19 Protein Revenue Market Share by Region (2019-2024)
Figure 50. APAC Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 51. APAC Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 52. China Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 56. India Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Covid-19 Protein Sales Market Share by Country in 2023
Figure 60. Europe Covid-19 Protein Revenue Market Share by Country (2019-2024)
Figure 61. Europe Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 62. Europe Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 63. Germany Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 64. France Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Covid-19 Protein Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Covid-19 Protein Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Covid-19 Protein Sales Market Share by Application (2019-2024)
Figure 71. Egypt Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Covid-19 Protein Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Covid-19 Protein in 2023
Figure 77. Manufacturing Process Analysis of Covid-19 Protein
Figure 78. Industry Chain Structure of Covid-19 Protein
Figure 79. Channels of Distribution
Figure 80. Global Covid-19 Protein Sales Market Forecast by Region (2025-2030)
Figure 81. Global Covid-19 Protein Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Covid-19 Protein Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Covid-19 Protein Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Covid-19 Protein Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Covid-19 Protein Revenue Market Share Forecast by Application (2025-2030)
